Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity

Animal studies demonstrate that hyperactive neurons facilitate early accumulation and spread of tau and amyloid-β proteins in the pathological cascade of Alzheimer's disease (AD). Human neuroimaging studies have linked hippocampal hyperactivity to amyloid-β accumulation, apolipoprotein ε4 (APOE4) and clinical progression from prodromal AD to clinical dementia. The relationship between hippocampal hyperactivity and early AD molecular pathology (amyloid-β and tau accumulation) before clinical symptoms remains to be elucidated. Here, we studied 120 clinically normal older humans (80 females/40 males) enrolled in the Harvard Aging Brain Study. We measured functional magnetic resonance imaging (fMRI) activity during successful memory encoding and amyloid-β accumulation with PiB-positron emission tomography imaging. Additionally, we measured tau accumulation using AV1451 PET imaging in a subset of 87 participants. In this subset, we found that inferior temporal tau accumulation was associated with increased fMRI activity in the hippocampus, but showed no clear association with amyloid. Together, the findings support a hypothetical model of the evolution of preclinical AD that place hippocampal hyperactivity concurrent with spread of tau pathology to neocortical regions before clinical impairment. SIGNIFICANCE STATEMENT The circumstances under which the hippocampus becomes hyperactive in preclinical stages of Alzheimer's disease (AD) have thus far remained elusive. Recent advances in positron emission tomography (PET) tracers now enable in vivo characterization of amyloid-β and tau accumulation. Here, we combine amyloid and tau PET with functional magnetic resonance imaging (fMRI) to examine the association between Alzheimer's disease pathology and memory-related brain activity in clinically normal older adults. We found an association between increased hippocampal activity and tau accumulation in the inferior temporal cortex. These data suggest that the pathogenesis of hippocampal hyperactivity occurs concurrent with the spread of tau pathology from the entorhinal cortex to the neocortex, before the clinical manifestations of Alzheimer's disease.

[1]  Richard J. Caselli,et al.  Hippocampal adaptation to face repetition in healthy elderly and mild cognitive impairment , 2004, Neuropsychologia.

[2]  A M Dale,et al.  Optimal experimental design for event‐related fMRI , 1999, Human brain mapping.

[3]  Kristen M. Kennedy,et al.  Effects of beta-amyloid accumulation on neural function during encoding across the adult lifespan , 2012, NeuroImage.

[4]  Keith A. Johnson,et al.  Amyloid-β Associated Cortical Thinning in Clinically Normal Elderly , 2011, Annals of neurology.

[5]  Maija Pihlajamäki,et al.  Increased fMRI responses during encoding in mild cognitive impairment , 2007, Neurobiology of Aging.

[6]  Adrian W. Gilmore,et al.  A parietal memory network revealed by multiple MRI methods , 2015, Trends in Cognitive Sciences.

[7]  Steven Mennerick,et al.  Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo , 2005, Neuron.

[8]  Denise C. Park,et al.  The adaptive brain: aging and neurocognitive scaffolding. , 2009, Annual review of psychology.

[9]  Christoph Laske,et al.  Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease , 2018, Brain : a journal of neurology.

[10]  R. Sperling,et al.  Age-related memory impairment associated with loss of parietal deactivation but preserved hippocampal activation , 2008, Proceedings of the National Academy of Sciences.

[11]  Anatol C. Kreitzer,et al.  Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.

[12]  L. Mucke,et al.  Network abnormalities and interneuron dysfunction in Alzheimer disease , 2016, Nature Reviews Neuroscience.

[13]  S. A. Hussaini,et al.  Neuronal activity enhances tau propagation and tau pathology in vivo , 2016, Nature Neuroscience.

[14]  Keith A. Johnson,et al.  The ups and downs of the posteromedial cortex: age- and amyloid-related functional alterations of the encoding/retrieval flip in cognitively normal older adults. , 2013, Cerebral cortex.

[15]  Kewei Chen,et al.  Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study , 2012, The Lancet Neurology.

[16]  Jorge Sepulcre,et al.  Tau positron emission tomographic imaging in aging and early Alzheimer disease , 2016, Annals of neurology.

[17]  Hwamee Oh,et al.  Frontotemporal Network Connectivity during Memory Encoding Is Increased with Aging and Disrupted by Beta-Amyloid , 2013, The Journal of Neuroscience.

[18]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[19]  Y. Stern,et al.  Cognitive reserve moderates the association between functional network anti-correlations and memory in MCI , 2017, Neurobiology of Aging.

[20]  Rebecca A Betensky,et al.  Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease , 2014, Neurology.

[21]  Amy L. Shelton,et al.  Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment , 2012, Neuron.

[22]  Denise C Park,et al.  The effect of beta‐amyloid on face processing in young and old adults: A multivariate analysis of the BOLD signal , 2015, Human brain mapping.

[23]  D. Holtzman,et al.  Neuronal activity regulates extracellular tau in vivo , 2014, The Journal of experimental medicine.

[24]  Y. Stern,et al.  Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve , 2013, Trends in Cognitive Sciences.

[25]  Jee Hoon Roh,et al.  Neuronal activity regulates the regional vulnerability to amyloid-β deposition , 2011, Nature Neuroscience.

[26]  M. Raichle,et al.  Searching for a baseline: Functional imaging and the resting human brain , 2001, Nature Reviews Neuroscience.

[27]  Keith A. Johnson,et al.  Imaging of amyloid burden and distribution in cerebral amyloid angiopathy , 2007, Annals of neurology.

[28]  Paul M. Matthews,et al.  Differential effects of the APOE genotype on brain function across the lifespan , 2011, NeuroImage.

[29]  Caroline L. Speck,et al.  Increased hippocampal activation in ApoE-4 carriers and non-carriers with amnestic mild cognitive impairment , 2016, NeuroImage: Clinical.

[30]  Jared Stokes,et al.  Temporal lobe functional activity and connectivity in young adult APOE ɛ4 carriers , 2010, Alzheimer's & Dementia.

[31]  Daniel R. Schonhaut,et al.  Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. , 2016, Brain : a journal of neurology.

[32]  William J Jagust,et al.  Hippocampal activation is associated with longitudinal amyloid accumulation and cognitive decline , 2017, eLife.

[33]  Caroline L. Speck,et al.  Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance , 2015, NeuroImage: Clinical.

[34]  Keith A. Johnson,et al.  Amyloid Deposition Is Linked to Aberrant Entorhinal Activity among Cognitively Normal Older Adults , 2014, The Journal of Neuroscience.

[35]  M. Gallagher,et al.  Heightened cortical excitability in aged rodents with memory impairment , 2017, Neurobiology of Aging.

[36]  Kewei Chen,et al.  Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study. , 2015, JAMA neurology.

[37]  M. Goodale,et al.  Separate visual pathways for perception and action , 1992, Trends in Neurosciences.

[38]  Chris M. Foster,et al.  Both hyper- and hypo-activation to cognitive challenge are associated with increased beta-amyloid deposition in healthy aging: A nonlinear effect , 2018, NeuroImage.

[39]  G L Shulman,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .

[40]  J. Karlawish,et al.  The A4 Study: Stopping AD Before Symptoms Begin? , 2014, Science Translational Medicine.

[41]  D. Holtzman,et al.  Antisense Reduction of Tau in Adult Mice Protects against Seizures , 2013, The Journal of Neuroscience.

[42]  Michela Gallagher,et al.  Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease , 2017, Neurotherapeutics.

[43]  Michael Erb,et al.  Hippocampal activation in patients with mild cognitive impairment is necessary for successful memory encoding , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[44]  Arthur Konnerth,et al.  Neuronal hyperactivity – A key defect in Alzheimer's disease? , 2015, BioEssays : news and reviews in molecular, cellular and developmental biology.

[45]  Keith A. Johnson,et al.  Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia , 2009, Neuron.

[46]  Reisa A. Sperling,et al.  Harvard Aging Brain Study: Dataset and accessibility , 2017, NeuroImage.

[47]  Bradford C. Dickerson,et al.  Tau PET imaging in aging and early Alzheimer's disease , 2015 .

[48]  R. Penn,et al.  Stiff‐man syndrome treated with intrathecal baclofen , 1993, Neurology.

[49]  Brian J Bacskai,et al.  A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. , 2002, Bioorganic & medicinal chemistry letters.

[50]  Cindee M. Madison,et al.  Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. , 2009, Brain : a journal of neurology.

[51]  Heidi E Kirsch,et al.  Incidence and impact of subclinical epileptiform activity in Alzheimer's disease , 2016, Annals of neurology.

[52]  Keith A. Johnson,et al.  The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials , 2014, Neuron.

[53]  William J. Jagust,et al.  Tau and β-Amyloid Are Associated with Medial Temporal Lobe Structure, Function, and Memory Encoding in Normal Aging , 2017, The Journal of Neuroscience.

[54]  Elizabeth C Mormino,et al.  Aβ Deposition in aging is associated with increases in brain activation during successful memory encoding. , 2012, Cerebral cortex.

[55]  Cindee M. Madison,et al.  Neural compensation in older people with brain β-amyloid deposition , 2014, Nature Neuroscience.

[56]  H. Kolb,et al.  [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease , 2013, Alzheimer's & Dementia.

[57]  K. Jellinger,et al.  Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.

[58]  Daniel R. Schonhaut,et al.  PET Imaging of Tau Deposition in the Aging Human Brain , 2016, Neuron.

[59]  Benjamin J. Shannon,et al.  Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.

[60]  Christopher G Schwarz,et al.  Longitudinal tau PET in ageing and Alzheimer’s disease , 2018, Brain : a journal of neurology.

[61]  C. Stark,et al.  Pattern separation in the hippocampus , 2011, Trends in Neurosciences.

[62]  S. M. Daselaar,et al.  When less means more: deactivations during encoding that predict subsequent memory , 2004, NeuroImage.

[63]  Sanford Weisberg,et al.  An R Companion to Applied Regression , 2010 .

[64]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[65]  Kaia L. Vilberg,et al.  Brain Networks Underlying Episodic Memory Retrieval This Review Comes from a Themed Issue on Macrocircuits Memory Signals within the Mtl , 2022 .

[66]  J. Pariente,et al.  Seizures in dominantly inherited Alzheimer disease , 2016, Neurology.

[67]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[68]  Thomas J. Wills,et al.  Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model , 2008, Proceedings of the National Academy of Sciences.

[69]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[70]  Keith A. Johnson,et al.  Functional network integrity presages cognitive decline in preclinical Alzheimer disease , 2017, Neurology.

[71]  Keith A. Johnson,et al.  Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. , 2015, Brain : a journal of neurology.

[72]  Maurizio Corbetta,et al.  The human brain is intrinsically organized into dynamic, anticorrelated functional networks. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[73]  L. Mucke,et al.  Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks , 2010, Nature Neuroscience.

[74]  G. Chételat,et al.  Neuroimaging biomarkers in Alzheimer’s disease and other dementias , 2016, Ageing Research Reviews.

[75]  Craig E. L. Stark,et al.  When zero is not zero: The problem of ambiguous baseline conditions in fMRI , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[76]  Mary Sano,et al.  Preventing Alzheimer’s Disease , 2008, CNS drugs.

[77]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[78]  R. Petersen,et al.  Recurrent seizures in patients with dementia: Frequency, seizure types, and treatment outcome , 2009, Epilepsy & Behavior.

[79]  Michael Schöll,et al.  Amyloid and tau PET demonstrate region-specific associations in normal older people , 2017, NeuroImage.

[80]  Sarah E. Wigman,et al.  Age-Related Increases in Tip-of-the-tongue are Distinct from Decreases in Remembering Names: A Functional MRI Study , 2016, Cerebral cortex.

[81]  Keith A. Johnson,et al.  A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers , 2016, Neurology.

[82]  Arthur Konnerth,et al.  Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease , 2008, Science.

[83]  David J. Schlyer,et al.  Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[84]  Ciprian Catana,et al.  Different partial volume correction methods lead to different conclusions: An 18F-FDG-PET study of aging , 2016, NeuroImage.

[85]  E. Mandelkow,et al.  Tau neurotoxicity and rescue in animal models of human Tauopathies , 2016, Current Opinion in Neurobiology.

[86]  A. Evans,et al.  Correction for partial volume effects in PET: principle and validation. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[87]  Heidi E Kirsch,et al.  Seizures and epileptiform activity in the early stages of Alzheimer disease. , 2013, JAMA neurology.

[88]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[89]  R. V. Van Heertum,et al.  Brain networks associated with cognitive reserve in healthy young and old adults. , 2005, Cerebral cortex.

[90]  Sterling C. Johnson,et al.  The Influence of Alzheimer Disease Family History and Apolipoprotein E ε4 on Mesial Temporal Lobe Activation , 2006, The Journal of Neuroscience.

[91]  Francisco Lopera,et al.  Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease , 2010, Annals of neurology.

[92]  M. Stoeckli,et al.  Dynamics of Aβ Turnover and Deposition in Different β-Amyloid Precursor Protein Transgenic Mouse Models Following γ-Secretase Inhibition , 2008, Journal of Pharmacology and Experimental Therapeutics.

[93]  W. Jagust.  Early life sets the stage for aging , 2016, Proceedings of the National Academy of Sciences.